STAT

NOVEMBER 18, 2022

The document says that public funding for the development of vaccines and treatments should be more transparent, and include provisions to ensure that any resulting products are distributed evenly around the world.

Diabetes 246

Diabetes Biosimilars Documentation Compounding 246

pharmaphorum

JANUARY 18, 2022

Main Conference: April 25 – 26, 2022 | Workshops: April 27, 2022. Chair for 2022: Gretchen Vandal, Sr. Featured 2022 Speakers Include: Joyce Zhao, Associate Director, Combination Product, Takeda. Understand requirements to facilitate the documentation preparation needed to obtain a NB Opinion.

Packaging 52

Packaging Documentation Vaccines Drug Development 52

European Pharmaceutical Review

JANUARY 16, 2023

This Q&A covers the key developments in pharmaceutical microbiology in 2022, featuring insight from pharmaceutical microbiology experts: Dr Tim Sandle, Head of Microbiology, Bio Products Laboratory Limited. Regulation, particularly Annex 1, was identified as a key focus for 2022.

Vaccines 128

Vaccines Research Laboratories Documentation Compounding 128

Putting Patients First Blog

APRIL 30, 2024

Key Points of Support Conciseness and Focus of Key Information The NHC supports the FDA’s emphasis on beginning the informed consent document with concise, focused presentations of key information. The importance of using plain language in health communications is well-documented in literature.

Documentation 52

Documentation Communication Mayo Clinic Drug Development 52

European Pharmaceutical Review

JANUARY 13, 2023

Commission (EPC) adopted the revised general monographs 2034 and 2619 , at its 174th session in November 2022 , which now includes a paragraph explaining the Ph. European Pharmacopoeia Commission’s November 2022 session highlights: Approval of the Ph. Priorities for 2022-2025. The European Pharmacopoeia (Ph. and non-Ph.

Documentation 105

Documentation Vaccines 105

Digital Pharmacist

NOVEMBER 21, 2022

On October 7 th , 2022 the U.S. a) Pandemic Factors: Health plans had previously been allowed to apply carryover quality criteria from 2021 and 2022. Road Towards Approval. However, in 2023, health plans should improve member engagement by scheduling a visit for preventative care or completing a missed screening.

Communication 98

Communication Documentation Pharmacy Management Immunity 98

Express Pharma

SEPTEMBER 13, 2024

From producing drugs for rare forms of cancer to generating highly effective vaccinations for various epidemics and pandemics, this industry has always played a pivotal role in safeguarding public health. million in 2022 and is predicted to reach USD 1,4290.95 This system assists in proper documentation and record-keeping.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Documentation Vaccines 105

pharmaphorum

NOVEMBER 23, 2022

Harking back to the Reuters Pharma 2022 event, held at the Nice Acropolis convention centre on France’s South Coast back in October, pharmaphorum had a chance to drop by the booth of EY and discuss not only its consulting operations, but the company’s Smart Reviewer, and their own assessment of the industry event itself.

Dosage 98

Dosage Documentation Hospitals Vaccines 98

pharmaphorum

APRIL 16, 2021

Even with the vaccine roll-out, further waves of COVID infection and lockdowns mean these vital drivers of launch performance remain impacted in 2021, and even beyond. The longer term impact of 2020 on clinical trial activity, given widely documented pauses on trials, will only be evaluable in coming years.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 95

Pharma in Brief

JANUARY 9, 2022

In response to the COVID-19 pandemic, in 2020, the Minister of Health signed interim orders designed to streamline the process to authorize the importation or sale of drugs, vaccines, and medical devices used to diagnose, treat, mitigate, or prevent COVID-19. The Amendments and the accompanying Guidelines are still not in force.

Documentation 52

Documentation Labelling Vaccines Packaging 52

Pharma in Brief

JANUARY 10, 2024

It now contemplates IT platforms ( e.g. , social media) and applies to drugs for use in humans as well as medical devices, natural health products, biologics, vaccines, and animal health products. We anticipate that the government will continue to advance the Digital Charter Implementation Act, 2022 (Bill C-27). Rare disease strategy.

Drug Pricing 52

Drug Pricing Documentation Biosimilars Vaccines 52

European Pharmaceutical Review

NOVEMBER 14, 2023

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105

Packaging Vaccines Documentation 105

The Happy PharmD

SEPTEMBER 15, 2024

Based on the data, the average distress level among pharmacists has decreased compared to previous reports spanning from 2019 to 2022. The stress experienced by community pharmacists compared to those in other settings is well-documented and has been a longstanding issue. It has declined from 3.25 in 2019 to 2.59.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Dosage Documentation Communication 52

National Association of Boards of Pharmacy

JULY 22, 2022

Many pharmacists can now administer diagnostic tests and vaccines, as well as dispense treatments for coronavirus disease 2019 (COVID-19). State and federal governments relaxed certain requirements and restrictions related to pharmacist and pharmacy technician licensing and scope of practice.

Pharmacy Technician 52

Pharmacy Technician Communication Documentation Vaccines 52

pharmaphorum

JANUARY 13, 2023

Sanofi Ventures invests in innovators working in areas including immunology and inflammation, rare diseases, oncology, cell and gene therapy, vaccines, and digital health and data science. The team partners across all stages of the private company lifecycle, from Seed to Series B and beyond.

Documentation 52

Documentation Vaccines 52

pharmaphorum

SEPTEMBER 14, 2022

With countless media stories regarding COVID-19 published over a period of several years, it was obvious that people around the globe were tuned in to every step of the fight against the pandemic, eagerly learning about everything from symptoms to vaccine development.

Vaccines 98

Vaccines Medical Records Documentation Communication 98

Putting Patients First Blog

JULY 22, 2024

This includes wholesalers, payers, and other entities involved in pricing and distribution, all of which significantly influence the availability and cost of medical products, including drugs, biologics, vaccines, and devices. Although these considerations extend beyond the current RFI, the NHC believes they warrant attention. 8 Wirtz, B.,

Documentation 52

Documentation Vaccines 52

pharmaphorum

JANUARY 9, 2023

1 Kenya, for example, entered the pandemic with no human vaccines manufacturing facility and established the BioVax institute for local vaccine manufacture with a major plant investment starting in 2023. Regulatory divergence became apparent in 2022 and could increase in 2023.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. Those available commercially include adenoviral-based vaccines by AstraZeneca and Johnson & Johnson. 2021 [Cited 16 September 2022].

Vaccines 115

Vaccines Documentation Communication Hospitals 115

Drug Channels

OCTOBER 10, 2023

addresses the Inflation Reduction Act of 2022. which examines the distribution of COVID-19 vaccines and therapeutics. There are 163 exhibits in this 2023-24 edition, compared with 150 in the 2022-23 edition. A new Section 6.3.2. In Subsection 6.5.1., we summarize the key provisions of the law that relate to prescription drugs.

Specialty Pharmacies 40

Specialty Pharmacies Biosimilars Pharmaceutical Manufacturing Documentation 40

Pharmaceutical Technology

SEPTEMBER 7, 2022

The following is adapted from a presentation given by Dave Par é and Silvio Scozzari at the DIA 2022 conference. The company has cemented its position as a reputable partner for CROs, with several major players in the race to develop vaccines and treatments for Covid-19 trusting it with critical projects. It has translated more than 6.3

Data Entry 52

Data Entry Vaccines Documentation Labelling 52

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. GlobalData pharmaceutical analysts project that RNA-based gene therapies for oncology will grow from zero in 2022 to $4.6 billion by 2028.

Vaccines 52

Vaccines Drug Development Documentation Communication 52

pharmaphorum

JULY 14, 2022

The European Commission’s failure to reveal text messages between president Ursula von der Leyen and Pfizer chief executive Albert Bourla on COVID-19 vaccine procurement has earned it a formal rebuke from the EU Ombudsman. billion doses of Pfizer and BioNTech’s vaccine. billion doses of Pfizer and BioNTech’s vaccine.

Documentation 52

Documentation Vaccines 52

Pharmaceutical Technology

NOVEMBER 15, 2022

Within Pfizer’s Covid-19 pipeline, Pfizer and BioNtech’s vaccine Comirnaty is also being used to fight the pandemic. While bivalent formulations of Comirnaty and Moderna’s Spikevax vaccine have both been authorised for use as boosters in the UK and US, their uptake has remained slow. Paxlovid rebound study.

Vaccines 64

Vaccines Documentation 64

Pharmaceutical Technology

NOVEMBER 3, 2022

There, Boehringer had earlier warned of the impending alteplase shortage in April 2022. After all, there have been united efforts before, pointing to the EU-wide Covid-19 vaccine procurement strategy as a good example, he says. Authorities from individual EU member states, like those from Czechia, have shared their individual warnings.

Dosage 111

Dosage Biosimilars Documentation Hospitals 111

Quality Matters

JUNE 21, 2023

In 2022 alone, six countries achieved ML3/ML4 for medicines and vaccines regulatory systems, leading to a call for increased adoption of risk-based approaches to post-marketing surveillance. To address the issue during the pandemic, USP produced a suite of resources targeting SF vaccines and treatments.

Communication 52

Communication Vaccines Documentation 52

LifeProNow

APRIL 19, 2023

The primary endpoint evaluated in this study is progression-free survival, defined as time from randomization to the first documentation of progressive disease or death due to any cause, whichever occurs first. The safety of immunization with live viral vaccines during or after ABECMA treatment has not been studied.

Adverse Reactions 100

Adverse Reactions Vaccines Immunity Immunization 100

pharmaphorum

NOVEMBER 16, 2022

The health technology assessment (HTA) agency has turned down five other COVID-19 therapies, notably AstraZeneca’s Evusheld (tixagevimab plus cilgavimab) – which patient organisations in the UK have been clamouring for access to, as it is an alternative to vaccinations for some vulnerable patient groups. The #cev struggle is real.

Vaccines 105

Vaccines Documentation 105

pharmaphorum

JULY 4, 2022

Part of the plan includes a pledge to “streamline and strengthen the regulatory environment to ensure faster approval, set-up and delivery of studies,” according to the new document, which also points to increased investment in “digitally focused trials.” — NIHR Research (@NIHRresearch) June 30, 2022.

Documentation 52

Documentation Vaccines 52

PharmaShots

JUNE 1, 2023

PDC*line is much more potent than conventional dendritic cell-based vaccines in priming and boosting antitumor antigen-specific cytotoxic T-cells, including the T-cells specific for neoantigens, and is synergistic with checkpoint inhibitors. Safety and clinical activity of the product were presented at ESMO 2022.

Immunity 40

Immunity Immunization Vaccines Health and Personal Care Stores 40

European Pharmaceutical Review

JUNE 27, 2022

A guidance document has been released to support these activities. The Kigali Summit on Malaria and NTDs , hosted by His Excellency (HE) Paul Kagame, President of the Republic of Rwanda, on Thursday 23 June 2022, gathered world leaders to commit to ending these devastating diseases by the end of 2030. — GSK (@GSK) June 23, 2022.

Vaccines 110

Vaccines Communication Documentation Compounding 110

European Pharmaceutical Review

FEBRUARY 17, 2023

The European Medicines Agency (EMA) has released a report detailing its Human Medicines Highlights 2022. The document contains an overview of the agency’s key recommendations in 2022. The highlights document summarised the most important recommendations on vaccines and treatments for COVID-19 and for mpox (monkeypox).

Documentation 98

Documentation Biosimilars Diabetes Vaccines 98

RX Note

FEBRUARY 23, 2023

- Discussing the 4 main drug targets Functional Groups - Quick refresh on IUPAC nomenclature Drug Potency - Refresh on drug potency Drug Metabolism - Discussing Phase I and II reactions, as well as CYP450 system Pharmacogenomics - Discussing some examples Miscellaneous Continuous Professional Development - Needed for renewal of annual retention Immunization (..)

HIV Treatment and Prevention Agents 58

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy 58

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Immunity Immunization 64

Putting Patients First Blog

SEPTEMBER 9, 2024

These codes facilitate proper documentation and reimbursement, ensuring that health care providers are fairly compensated for the critical services they offer. Preventive Services The expansion of preventive services, including hepatitis B vaccinations and colorectal cancer screenings, is a positive development for public health.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Documentation Vaccines Communication 40

pharmaphorum

APRIL 7, 2022

It is too early to consider widespread use of a second COVID-19 vaccine booster dose, according to the European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF). FDA gives first thinking on updating vaccines.

Vaccines 59

Vaccines Immunity Immunization Documentation 59

The Thyroid Pharmacist

NOVEMBER 8, 2024

A new test is being developed for MAP detection in support of a vaccine for Crohn’s disease; it has been in clinical trials, and looks very promising. Researchers found they could suppress the autoimmune response if using a vaccine or antibiotic that specifically eradicates E. Published 2022 Aug 24. Published 2022 Apr 6.

Immunity 73

Immunity Immunization Diabetes Adverse Reactions 73